Hi Mozzarc,
Hope you are well! Just trying to get my facts right, given you are one of the SME of this stock here in HC, do I miss anything on the below?
Potential Catalysts for PAR for the rest of CY2019: (in chronological order)
1) Potential feedbacks on the treatment for the NFL players under the EA IND with the FDA (should be in late Oct or so?)
2) TGA Provisional Approval (Australia) for OA - has this been delayed to Q4? On my investment note, it was marked it could be for Q3 and we can start generating small scale revenue following submissions. Or did I mixed up the Special Access Scheme (SAS) with Provisional Approval?
3) Pre-IND meeting Phase 3 for osteoarthritis (US FDA) - Expected Q4 as confirmed by management
4) Pre-IND for Phase 2/3 for the rare disease mucopolysaccharidosis (US FDA) - Expected Q4 as confirmed by management
5) Potential TGA SAS for MPS patients in Australia
Is there anything I missed or is there any assumptions that are incorrect?
Thank you!
- Forums
- ASX - By Stock
- PAR
- Current SP appreciation
Current SP appreciation, page-155
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.95M |
Open | High | Low | Value | Volume |
22.0¢ | 23.5¢ | 22.0¢ | $66.95K | 294.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 90092 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 25858 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 90092 | 0.220 |
7 | 93958 | 0.215 |
7 | 143016 | 0.210 |
4 | 104982 | 0.205 |
6 | 89975 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 25858 | 1 |
0.240 | 40833 | 1 |
0.245 | 37318 | 1 |
0.250 | 15000 | 1 |
0.255 | 9785 | 1 |
Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |